Mostra i principali dati dell'item

dc.creatorPapaioannou, A. I.en
dc.creatorKostikas, K.en
dc.creatorGerogianni, E.en
dc.creatorIoannou, M.en
dc.creatorGourgouliannis, K. I.en
dc.date.accessioned2015-11-23T10:43:38Z
dc.date.available2015-11-23T10:43:38Z
dc.date.issued2008
dc.identifier.issn11053992
dc.identifier.urihttp://hdl.handle.net/11615/31811
dc.description.abstractAnti-TNF-α agents have been used for the treatment of several autoimmune diseases, including rheumatoid arthritis. Recently observations indicate that treatment with anti-TNF-α agents is associated with increased risk of infectious diseases and especially tuberculosis. A case of a 78-year-old female with rheumatoid arthritis is described who developed miliary tuberculosis after treatment with infliximab. A brief review of the literature is presented. Copyright © Athens Medical Society.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-45849102015&partnerID=40&md5=9eab9eb89ad224b40fd8e068ee9f8671
dc.subjectAnti-TNF-αen
dc.subjectInfliximaben
dc.subjectRheumatoid arthritisen
dc.subjectTuberculosisen
dc.subjecttumor necrosis factor alpha antibodyen
dc.subjectageden
dc.subjectarticleen
dc.subjectcase reporten
dc.subjectclinical featureen
dc.subjectdisease courseen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectinfection risken
dc.subjectmiliary tuberculosisen
dc.titleMiliary tuberculosis in a patient with rheumatoid arthritis following treatment with anti-TNF-αen
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item